Based on the receptor status, human breast cancer can be subdivided into three main groups: oestrogen receptor positive (ER+), human epidermal growth factor receptor 2 positive (HER2+) and triple negative (ER−/PR−/HER2–). Here, PGR is linked to breast carcinoma.